An Open, Single-center Study to Determine the Antibody Repsonse to Gastrimmune and Its Safety and Tolerability in Patients With Advanced Pancreatic Carcinoma
Clinical trial NCT02098291 · COMPLETED
Trial details
- NCT number
- NCT02098291
- Sponsor
- Cancer Advances Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-04-01
- Primary completion
- 2001-07-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.